Buy Suven Life Sciences, target Rs 312: Kunal Bothra

Independent Analyst Kunal Bothra has a buy call on Suven Life Sciences Ltd. with a target price of Rs 312.0 . The current market price of Suven Life Sciences Ltd. is Rs 293.7. Time period given by the analyst is Intra Day when Suven Life Sciences Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 280. Suven Life Sciences Ltd., incorporated in 1989, has a market cap of Rs 3738.29 crore.
Suven Life Sciences Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates) which contributed Rs 595.47 Crore to Sales Value (89.74 % of Total Sales), Sale of services which contributed Rs 49.88 Crore to Sales Value (7.51 % of Total Sales), Export Incentives which contributed Rs 16.92 Crore to Sales Value (2.55 % of Total Sales) and Duty Drawback which contributed Rs 1.23 Crore to Sales Value (0.18 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 198.99 Crore, down -21.44 % from last quarter Sales of Rs 253.30 Crore and up 3.82 % from last year same quarter Sales of Rs 191.66 Crore Company has reported net profit after tax of Rs 26.21 Crore in latest quarter. The company’s top management includes Dr.M R Naidu, Mr.D G Prasad, Mr.M Gopalakrishna, Mr.Santanu Mukherjee, Mr.Venkateswarlu Jasti, Mrs.J A S Padmaja, Mrs.Sudharani Jasti, Prof.Seyed E Hasnain. Company has Tukaram & Co. LLP as its auditors. As on 30-06-2019, the company has a total of 127,282,478 shares outstanding.